Patent directory · USPTO A61K / A61P
Patents matching “Julius-Maximilians-Universitat Wurzburg”
39 pharma patents match "Julius-Maximilians-Universitat Wurzburg" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 39 pharmaceutical patents matching "Julius-Maximilians-Universitat Wurzburg" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9220722
Microrna (miRNA) and downstream targets for diagnostic and therapeutic purposes
granted -
US 9155778
Tripeptides that down regulate the activity of plasma membrane transporters including sodium-D-glucose cotransporter SgIt1
granted -
US 9062095
Mutant double cyclized receptor peptides inhibiting β1-adrenoceptor antibodies
granted -
US 8906870
MicroRNA (miRNA) for the diagnosis and treatment of heart diseases
granted -
US 8877718
Antiinfective and antitumoral compounds isolated from tropical lianas
granted -
US 8796428
Erk1/2 posphorylation site specific antibody
granted -
US 8691783
MicroRNA-24
granted -
US 8592389
MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes
granted -
US 8425492
In vivo device, system and usage thereof
granted -
US 8236777
MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes
granted -
US 8207133
Peptides that down regulate the activity of plasma membrane transporters including sodium-D-glucose cotransporter SGLT1
granted -
US 8187605
Means for the inhibition of anti-β1-adrenergic receptor antibodies
granted -
US 8173673
Biofilm-inhibiting effect and anti-infective activity of N,C-linked aryl isoquinolines and the use thereof
granted -
US 7928057
Peptide for inhibition of calcineurin, nucleic acid, antibody, and diagnostic and therapeutic methods of use
granted -
US 7786080
Mutein of a bone morphogenetic protein and use thereof
granted